Search results
Showing 2596 to 2610 of 7685 results
In development [GID-NG10427] Expected publication date: 04 February 2025
In development [GID-TA10907] Expected publication date: 30 April 2025
We are listening to your views on this NICE guideline. Comments close 29 November 2024.
In development [GID-IPG10267] Expected publication date: 14 August 2025
In development [GID-IPG10268] Expected publication date: 08 January 2025
Balloon disimpaction of the baby's head at emergency caesarean during the second stage of labour
In development [GID-IPG10408] Expected publication date: 16 April 2025
Dupilumab for treating severe chronic rhinosinusitis with nasal polyposis (Review of TA648) [ID6480]
In development [GID-TA11630] Expected publication date: 11 September 2025
Vutrisiran for treating transthyretin-related amyloidosis with cardiomyopathy [ID6470]
In development [GID-TA11598] Expected publication date: TBC
Evidence-based recommendations on Kinesia 360 and KinesiaU (Great Lakes NeuroTechnologies), PDMonitor (PD Neurotechnology), Personal KinetiGraph (Global Kinetics) and STAT-ON (Sense4care) for remote monitoring of Parkinson’s disease
Evidence-based recommendations on therapeutic monitoring of tumour necrosis factor (TNF)-alpha inhibitors (LISA-TRACKER, IDKmonitor and Promonitor ELISA kits) in people with Crohn’s disease
Evidence-based recommendations on viscoelastometric point-of-care testing devices (the ROTEM, TEG and Sonoclot systems)
Fluorouracil chemotherapy: The My5‑FU assay for guiding dose adjustment (DG16)
Evidence-based recommendations on the My5-FU assay for measuring levels of 5-flurouracil (5-FU) in patients having chemotherapy, to help guide changes to the
Depth of anaesthesia monitors – Bispectral Index (BIS), E-Entropy and Narcotrend-Compact M (DG6)
Evidence-based recommendations on 3 electroencephalography (EEG)-based depth of anaesthesia monitors for assessing a patient’s response to anaesthetic drugs during surgery. The monitors are Bispectral Index (BIS), E-Entrophy and Narcotrend-Compact M
Evidence-based recommendations on the RD-100i OSNA system and Metasin test for detecting sentinel lymph node metastases in people having breast cancer surgery
Evidence-based recommendations on testing for epidermal growth factor receptor tyrosine kinase (EGFR–TK) mutations in untreated, locally advanced or metastatic